Method for enhanced delivery of oxybutynin and compositions thereof
AssigneeTheramax, Inc.
InventorsAmanda J. Sherratt, Abdulghani A. Houdi
Life of this patent
Estimating the term…
Abstract
This invention provides to a method for enhancement of systemic delivery of oxybutynin by administration via the nasal route, and methods of treatment comprising intranasal administration of oxybutynin. The present invention further provides pharmaceutical compositions comprising oxybutynin and/or pharmaceutically acceptable salts thereof.
Claims20
A method of providing oxybutynin therapy to a patient in need thereof comprising intranasally administering an effective amount of oxybutynin or a pharmaceutically acceptable salt thereof to said patient.
A pharmaceutical composition comprising oxybutynin and a pharmaceutically acceptable carrier suitable for nasal administration.
A method of reducing side effects associated with oxybutynin therapy comprising administering a therapeutically effective amount of oxybutynin intranasally, said intranasal administration reducing side effects associated with the oral administration of an equivalent dose of oxybutynin.
Dependencies are inferred from the claim text.